LMR Partners LLP Invests $197,000 in Enhabit, Inc. (NYSE:EHAB)

LMR Partners LLP acquired a new stake in shares of Enhabit, Inc. (NYSE:EHAB) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 24,967 shares of the company’s stock, valued at approximately $197,000.

Several other large investors have also modified their holdings of EHAB. Kent Lake Capital LLC acquired a new stake in Enhabit in the first quarter worth approximately $5,183,000. Marshall Wace LLP purchased a new stake in shares of Enhabit in the second quarter valued at $1,941,000. DekaBank Deutsche Girozentrale grew its stake in Enhabit by 52.3% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after acquiring an additional 178,000 shares in the last quarter. WINTON GROUP Ltd purchased a new position in Enhabit during the second quarter valued at approximately $955,000. Finally, GSA Capital Partners LLP grew its holdings in shares of Enhabit by 78.4% during the 3rd quarter. GSA Capital Partners LLP now owns 142,012 shares of the company’s stock valued at $1,122,000 after acquiring an additional 62,397 shares in the last quarter.

Analyst Ratings Changes

Separately, Leerink Partners restated a “market perform” rating and set a $8.00 price target (down previously from $8.50) on shares of Enhabit in a report on Tuesday. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $9.25.

Enhabit Stock Up 2.6 %

NYSE EHAB opened at $7.46 on Thursday. The stock has a fifty day moving average of $7.52 and a 200-day moving average of $8.42. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The stock has a market capitalization of $375.12 million, a P/E ratio of -3.22 and a beta of 1.84. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $11.74.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the company earned $0.03 earnings per share. On average, equities research analysts forecast that Enhabit, Inc. will post 0.25 EPS for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.